10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001144204-18-060040`
Period End Date	20180930
Filing Date	20181114
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	ameh-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 84 Cash Flow Statement 123

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$119.78M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$99.75M	USD	Point-in-time
Restricted cash - short-term	`RestrictedCashCurrent`	$18.01M	USD	Point-in-time
Restricted cash - short-term	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash - short-term	`RestrictedCashCurrent`	$4.22M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Fiduciary cash	`AssetsHeldInTrustCurrent`	$2.02M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Fiduciary cash	`AssetsHeldInTrustCurrent`	$3.43M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.14M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$1.14M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	32.30M	shares	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$20.12M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$70.08M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	33.03M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.13M	USD	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	1.68M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.18M	USD	Point-in-time
Treasury Stock, Common, Shares	`TreasuryStockCommonShares`	1.68M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$202.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$144.16M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.81M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.91M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$90.76M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$103.53M	USD	Point-in-time
Goodwill	`Goodwill`	$189.85M	USD	Point-in-time
Goodwill	`Goodwill`	$189.60M	USD	Point-in-time
Loans receivable - related parties	`DueFromRelatedPartiesNoncurrent`	$7.50M	USD	Point-in-time
Loans receivable - related parties	`DueFromRelatedPartiesNoncurrent`	$5.00M	USD	Point-in-time
Loan receivable	`LoansReceivableNet`	$10.00M	USD	Point-in-time
Loan receivable	`LoansReceivableNet`	$5.00M	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValuePerShare`	-	USD	Point-in-time
Investment in a privately held entity that does not report net asset value per share	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValuePerShare`	$405.00K	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$24.12M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$21.90M	USD	Point-in-time
Investment in joint venture equity method	`InvestmentsInJointVenture`	-	USD	Point-in-time
Investment in joint venture equity method	`InvestmentsInJointVenture`	$16.67M	USD	Point-in-time
Restricted cash - long-term	`RestrictedCashNoncurrent`	$745.41K	USD	Point-in-time
Restricted cash - long-term	`RestrictedCashNoncurrent`	-	USD	Point-in-time
Restricted cash - long-term	`RestrictedCashNoncurrent`	$745.24K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.34M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.63M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$346.48M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$349.07M	USD	Point-in-time
Total assets	`Assets`	$490.64M	USD	Point-in-time
Total assets	`Assets`	$551.90M	USD	Point-in-time
Lines of credit, short-term	`LinesOfCreditCurrent`	$5.03M	USD	Point-in-time
Lines of credit, short-term	`LinesOfCreditCurrent`	-	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$13.28M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$44.97M	USD	Point-in-time
Incentives payable	`IncentivePayableCurrent`	$5.00M	USD	Point-in-time
Incentives payable	`IncentivePayableCurrent`	$21.50M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$2.02M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$3.43M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$63.97M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$18.96M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$33.51M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$1.29M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$3.20M	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	$510.39K	USD	Point-in-time
Bank loan	`ShortTermBankLoansAndNotesPayable`	$159.91K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$3.78M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Capital lease obligations	`CapitalLeaseObligationsCurrent`	$98.74K	USD	Point-in-time
Capital lease obligations	`CapitalLeaseObligationsCurrent`	$100.98K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$92.25M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$109.60M	USD	Point-in-time
Lines of credit, long-term	`LongTermLineOfCredit`	$13.00M	USD	Point-in-time
Lines of credit, long-term	`LongTermLineOfCredit`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$24.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$34.65M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Liability for unissued equity shares	`LiabilityForUnissuedEquitySharesNoncurrent`	$1.19M	USD	Point-in-time
Dividends payable	`DividendPayableNoncurrent`	$18.00M	USD	Point-in-time
Dividends payable	`DividendPayableNoncurrent`	-	USD	Point-in-time
Capital lease obligations, net of current portion	`CapitalLeaseObligationsNoncurrent`	$619.00K	USD	Point-in-time
Capital lease obligations, net of current portion	`CapitalLeaseObligationsNoncurrent`	$542.98K	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$44.72M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$49.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$154.32M	USD	Point-in-time
Total liabilities	`Liabilities`	$141.62M	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Pacific of California IPA ("APC")	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$225.15M	USD	Point-in-time
Noncontrolling interest in Allied Pacific of California IPA ("APC")	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$172.13M	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 33,025,189 and 32,304,876 shares outstanding, excluding 1,682,110 treasury shares held by APC, at September 30, 2018 and December 31, 2017, respectively (see Note 10)	`CommonStockValue`	$33.02K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 33,025,189 and 32,304,876 shares outstanding, excluding 1,682,110 treasury shares held by APC, at September 30, 2018 and December 31, 2017, respectively (see Note 10)	`CommonStockValue`	$32.30K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$162.81M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$158.18M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.73M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$17.10M	USD	Point-in-time
Stockholders' Equity Attributable to Parent	`StockholdersEquity`	$159.95M	USD	Point-in-time
Stockholders' Equity Attributable to Parent	`StockholdersEquity`	$179.94M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$5.18M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.24M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$185.13M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$490.64M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$551.90M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`Revenues`	$167.28M	USD	1 Quarter
Total revenue	`Revenues`	$97.13M	USD	1 Quarter
Total revenue	`Revenues`	$263.78M	USD	3 Qtrs
Total revenue	`Revenues`	$414.45M	USD	3 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$192.95M	USD	3 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$66.74M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$96.83M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$281.72M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$15.43M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$31.48M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$9.03M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.38M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.76M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.41M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.82M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.84M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$222.79M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$328.02M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$110.70M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$75.88M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$40.99M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$56.58M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$21.25M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$86.43M	USD	3 Qtrs
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-1.46M	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-28.94K	USD	3 Qtrs
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.22M	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-2.57M	USD	3 Qtrs
Interest expense	`InterestExpense`	$16.37K	USD	3 Qtrs
Interest expense	`InterestExpense`	$178.32K	USD	1 Quarter
Interest expense	`InterestExpense`	$374.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$14.98K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$618.64K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$226.86K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$343.37K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$953.00K	USD	3 Qtrs
Change in fair value of derivative instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$-278.89K	USD	3 Qtrs
Change in fair value of derivative instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$-406.67K	USD	1 Quarter
Change in fair value of derivative instruments	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	3 Qtrs
Change in fair value of derivative instruments	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$1.11M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$122.61K	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$94.47K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$684.28K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$417.06K	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$-1.56M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-881.28K	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$-3.37M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$19.69M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$41.41M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$85.55M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$53.21M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$16.49M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$14.59M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$23.34M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$7.87M	USD	1 Quarter
Net income	`ProfitLoss`	$11.82M	USD	1 Quarter
Net income	`ProfitLoss`	$24.91M	USD	3 Qtrs
Net income	`ProfitLoss`	$62.21M	USD	3 Qtrs
Net income	`ProfitLoss`	$38.63M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$12.95M	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$48.28M	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.20M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$29.52M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$9.11M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$11.96M	USD	3 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$5.62M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$13.93M	USD	3 Qtrs
Earnings per share - basic	`EarningsPerShareBasic`	$0.28	USD	1 Quarter
Earnings per share - basic	`EarningsPerShareBasic`	$0.22	USD	1 Quarter
Earnings per share - basic	`EarningsPerShareBasic`	$0.48	USD	3 Qtrs
Earnings per share - basic	`EarningsPerShareBasic`	$0.43	USD	3 Qtrs
Earnings per share - diluted	`EarningsPerShareDiluted`	$0.20	USD	1 Quarter
Earnings per share - diluted	`EarningsPerShareDiluted`	$0.37	USD	3 Qtrs
Earnings per share - diluted	`EarningsPerShareDiluted`	$0.42	USD	3 Qtrs
Earnings per share - diluted	`EarningsPerShareDiluted`	$0.24	USD	1 Quarter
Weighted average shares of common stock outstanding-basic	`WeightedAverageNumberOfSharesOutstandingBasic`	25.07M	shares	3 Qtrs
Weighted average shares of common stock outstanding-basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.67M	shares	3 Qtrs
Weighted average shares of common stock outstanding-basic	`WeightedAverageNumberOfSharesOutstandingBasic`	25.07M	shares	1 Quarter
Weighted average shares of common stock outstanding-basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.92M	shares	1 Quarter
Weighted average shares of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.42M	shares	3 Qtrs
Weighted average shares of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.39M	shares	1 Quarter
Weighted average shares of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.01M	shares	3 Qtrs
Weighted average shares of common stock outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.42M	shares	1 Quarter

Cash Flow Statement 123 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$11.82M	USD	1 Quarter
Net income	`ProfitLoss`	$24.91M	USD	3 Qtrs
Net income	`ProfitLoss`	$62.21M	USD	3 Qtrs
Net income	`ProfitLoss`	$38.63M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.76M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.41M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.82M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.84M	USD	1 Quarter
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-41.78K	USD	3 Qtrs
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$1.24M	USD	3 Qtrs
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$963.70K	USD	3 Qtrs
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$202.38K	USD	1 Quarter
Share-based compensation	`AllocatedShareBasedCompensationExpense`	$321.23K	USD	1 Quarter
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$79.53K	USD	3 Qtrs
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-10.22K	USD	3 Qtrs
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$-278.89K	USD	3 Qtrs
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	$-406.67K	USD	1 Quarter
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	3 Qtrs
Change in fair value of derivative instrument	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-1.46M	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-28.94K	USD	3 Qtrs
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.22M	USD	1 Quarter
Loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-2.57M	USD	3 Qtrs
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$-5.73M	USD	3 Qtrs
Deferred tax	`DeferredIncomeTaxExpenseBenefit`	$7.14M	USD	3 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$38.37M	USD	3 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$-263.13K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$590.60K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$736.52K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$26.93K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$131.98K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$31.70M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.90M	USD	3 Qtrs
Incentives payable	`IncreaseDecreaseInIncentivesPayable`	$-7.94M	USD	3 Qtrs
Incentives payable	`IncreaseDecreaseInIncentivesPayable`	$-16.50M	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-30.47M	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-752.88K	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$12.73M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-1.91M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$36.32M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$31.86M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$9.01K	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.28K	USD	3 Qtrs
Repayments from related parties loans receivable	`RepaymentOfNotesReceivableFromRelatedParties`	$200.00K	USD	3 Qtrs
Repayments from related parties loans receivable	`RepaymentOfNotesReceivableFromRelatedParties`	-	USD	3 Qtrs
Advances to related parties - loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$5.00M	USD	3 Qtrs
Advances to related parties - loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$2.50M	USD	3 Qtrs
Purchase of investments joint venture	`PaymentsToAcquireInterestInJointVenture`	$400.00K	USD	3 Qtrs
Purchase of investments joint venture	`PaymentsToAcquireInterestInJointVenture`	$16.67M	USD	3 Qtrs
Dividends received from equity method investments	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$207.41K	USD	3 Qtrs
Dividends received from equity method investments	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$1.00M	USD	3 Qtrs
Purchase of investment in a privately held entity	`PurchaseOfInvestmentsInPrivatelyHeldEntityThatDoesNotReportNetAssetValuePerShare`	-	USD	3 Qtrs
Purchase of investment in a privately held entity	`PurchaseOfInvestmentsInPrivatelyHeldEntityThatDoesNotReportNetAssetValuePerShare`	$405.00K	USD	3 Qtrs
Proceeds on sale of investments - cost method	`ProceedsFromSaleOfCostMethodInvestments`	$25.00K	USD	3 Qtrs
Proceeds on sale of investments - cost method	`ProceedsFromSaleOfCostMethodInvestments`	-	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$867.73K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.63M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.25M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.81M	USD	3 Qtrs
Repayment of bank loan	`RepaymentsOfRelatedPartyDebt`	$375.49K	USD	3 Qtrs
Repayment of bank loan	`RepaymentsOfRelatedPartyDebt`	-	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$16.73M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$9.49M	USD	3 Qtrs
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	3 Qtrs
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	$27.30K	USD	3 Qtrs
Borrowings on line of credit	`ProceedsFromLinesOfCredit`	$8.00M	USD	3 Qtrs
Borrowings on line of credit	`ProceedsFromLinesOfCredit`	-	USD	3 Qtrs
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$78.34K	USD	3 Qtrs
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$73.78K	USD	3 Qtrs
Proceeds from sale of common stock of VIE	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from sale of common stock of VIE	`ProceedsFromIssuanceOfCommonStock`	$200.00K	USD	3 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromStockOptionsExercised`	$3.57M	USD	3 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromStockOptionsExercised`	$425.02K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.37M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.14M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$6.24M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$21.37M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.93M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.93M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.29M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$9.49M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$18.03M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$287.33K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$1.75K	USD	3 Qtrs
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	-	USD	3 Qtrs
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	$47.00	USD	3 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustmentToGoodwill`	$1.11M	USD	3 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustmentToGoodwill`	-	USD	3 Qtrs
Cumulative effect adjustment for ASC 606 included in accounts receivable	`CumulativeEffectAdjustmentIncludedInAccountsReceivable`	-	USD	3 Qtrs
Cumulative effect adjustment for ASC 606 included in accounts receivable	`CumulativeEffectAdjustmentIncludedInAccountsReceivable`	$11.60M	USD	3 Qtrs
Cumulative effect adjustment for ASC 606 included in deferred tax liabilities	`CumulativeEffectAdjustmentIncludedInDeferredTaxLiabilities`	-	USD	3 Qtrs
Cumulative effect adjustment for ASC 606 included in deferred tax liabilities	`CumulativeEffectAdjustmentIncludedInDeferredTaxLiabilities`	$3.25M	USD	3 Qtrs
Purchase price adjustment for acceleration of vested stock options	`PurchasePriceAdjustmentForAccelerationOfVestedStockOptions`	$868.00K	USD	3 Qtrs
Purchase price adjustment for acceleration of vested stock options	`PurchasePriceAdjustmentForAccelerationOfVestedStockOptions`	-	USD	3 Qtrs
Conversion of loan receivable to investment in Accountable Health Care, IPA	`NoncashOrPartNoncashAcquisitionConversionOfLoanReceivableToInvestmentInterest`	$5.00M	USD	3 Qtrs
Conversion of loan receivable to investment in Accountable Health Care, IPA	`NoncashOrPartNoncashAcquisitionConversionOfLoanReceivableToInvestmentInterest`	-	USD	3 Qtrs
Reclassification of dividends payable to accounts payable and accrued expenses	`DividendsPayableCurrentAndNoncurrent`	$432.11K	USD	Point-in-time
Reclassification of dividends payable to accounts payable and accrued expenses	`DividendsPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Reclassification of APS noncontrolling interest to equity	`ReclassificationOfAPSNoncontrollingInterestToEquity`	$443.18K	USD	3 Qtrs
Reclassification of APS noncontrolling interest to equity	`ReclassificationOfAPSNoncontrollingInterestToEquity`	-	USD	3 Qtrs
Reclassification of stock options exercised to liability for unissued common shares	`StockIssued1`	-	USD	3 Qtrs
Reclassification of stock options exercised to liability for unissued common shares	`StockIssued1`	$425.02K	USD	3 Qtrs
Reclassification of fiduciary cash to payable	`LiabilitiesAssumed1`	$1.42M	USD	3 Qtrs
Reclassification of fiduciary cash to payable	`LiabilitiesAssumed1`	$51.52K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$119.78M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$99.75M	USD	Point-in-time
Restricted cash - long-term - letters of credit	`RestrictedCashNoncurrent`	$745.41K	USD	Point-in-time
Restricted cash - long-term - letters of credit	`RestrictedCashNoncurrent`	-	USD	Point-in-time
Restricted cash - long-term - letters of credit	`RestrictedCashNoncurrent`	$745.24K	USD	Point-in-time
Restricted cash - short-term - distributions to former NMM shareholders	`RestrictedCashCurrent`	$18.01M	USD	Point-in-time
Restricted cash - short-term - distributions to former NMM shareholders	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash - short-term - distributions to former NMM shareholders	`RestrictedCashCurrent`	$4.22M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.93M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.29M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$124.74M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.